Prostate Cancer News and Features TOC

109 32
Prostate Cancer News and Features TOC

Tools & Resources



News and FeaturesRelated to Prostate Cancer

  1. New Doubts on Value of Prostate Cancer Screening

    March 31, 2011 -- A study from Sweden raises new questions about the value of screening average-risk men for prostate cancer. In the study, screening did not significantly reduce prostate cancer deaths over two decades of follow-up, but it did result in the detection of more cases of the cancer and
    Read Full Article
  2. New Insight on Weight Gain After Prostate Cancer Therapy

    March 14, 2011 -- Many men with prostate cancer will get treatments to block male hormones like testosterone in an effort to keep their cancer from spreading. There are several recognized side effects associated with those therapies, including hot flashes, loss of interest in sex, erectile dysfuncti
    Read Full Article
  3. Can Pomegranate Pills Fight Prostate Cancer?

    Feb. 17, 2011 (Orlando, Fla.) -- Taking a pomegranate pill a day may help slow the progression of prostate cancer, preliminary research suggests. The study is the latest to demonstrate pomegranate's promising antitumor effects, says study head Michael Carducci, MD, professor of oncology and urology
    Read Full Article
  4. Gene Test for Prostate Cancer in the Works

    Feb. 17, 2011 (Orlando, Fla.) -- Researchers are a step closer to developing a genetic test that could help men with newly diagnosed prostate cancer decide whether they are good candidates for active surveillance or whether they need treatment right away. "The biggest challenge with newly diagnosed
    Read Full Article
  5. Study: Prostate Cancer Imaging Scans Often Unnecessary

    Feb. 18, 2011 (Orlando) -- Thousands of men with low-risk prostate cancer are having unnecessary and expensive imaging tests, while thousands of men with high-risk disease who should get the tests are not. When men are diagnosed with prostate cancer, they are classified as low-, intermediate-, or hi
    Read Full Article
  6. Is Early Balding Linked to Prostate Cancer?

    Feb. 15, 2011 -- Men who start to go bald by age 20 may have an increased risk for developing prostate cancer later in life, a study suggests. Prostate cancer patients in the study were twice as likely to report that they began to lose their hair by this age as men who did not have the disease. The
    Read Full Article
  7. New Debate on PSA Test for Prostate Cancer

    Feb. 15, 2010 -- Men with a PSA (prostate-specific antigen) level of less than 1 nanogram per liter of blood can safely wait up to eight years between PSA screenings, researchers say. And men with PSA levels of less than 3 at the time of the first screening test do not need biopsies to check for pro
    Read Full Article
  8. Strategy for Incontinence From Prostate Cancer Surgery

    Jan. 11, 2011 -- Pelvic-floor-muscle exercises along with other bladder control strategies, such as keeping a diary and monitoring your daily fluid intake, can help halve weekly incontinence episodes among men with prostate cancer who have had surgery to remove their prostate gland (radical prostate
    Read Full Article
  9. Exercise Cuts Prostate Cancer Death Risk

    Jan. 6, 2011 -- Men diagnosed with prostate cancer may be able to reduce their risk of death not just from prostate cancer but from any cause by exercising vigorously for at least three hours per week, new research indicates. A study performed by researchers at the Harvard School of Public Health an
    Read Full Article
  10. FDA Panel Rejects Drugs to Prevent Prostate Cancer

    Dec. 1, 2010 -- An FDA advisory committee has voted against approval of two drugs for the prevention of prostate cancer because of a link to increased risk of high-grade, aggressive forms of the disease. GlaxoSmithKline’s Avodart and Merck’s Proscar are approved to treat benign prostatic hyperplasia
    Read Full Article

Displaying 101 - 110of 422 Articles<<Prev Page7891011 1213141516Next>>
Source...

Leave A Reply

Your email address will not be published.